Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostasis del calcio - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

sun pharmaceutical industries s.a.c. - solucion oftalmica - por dosis - lágrimas artificiales y otros preparados inertes

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - atorvastatina cálcica 21.69 mg equivalente a 20 mg de atorvastatina - tabletas - cada tableta contiene: atorvastatina cálcica 21.69 mg equivalente a 20 mg de atorvastatina

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - atorvastatina 10 mg - tabletas - cada tableta contiene: atorvastatina cálcica 10.84 mg equivalente a 10 mg de atorvastatina

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - amlodipina besilato* bp 6.93 mg equvalente a 5 mg de amlodipina - tabletas - cada tableta contiene: amlodipina besilato* bp 6.93 mg equvalente a 5 mg de amlodipina

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - amlodipina besilato*bp 13.86 mg equivalente a 10 mg de amlodipina - tableta - cada tableta contiene: amlodipina besilato* bp 13.86 mg equivalente a 10 mg de amlodipina

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - esomeprazol 40.00 mg - tableta de liberacion controlada - cada tableta de liberación retardada contiene: esomeprazol del magnesio 41.400mg* correspondiente a esomeprazol 40.00mg

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - glibenclamida 5.0mg - tabletas - cada tableta contiene: glibenclamida 5.0 mg

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

sun pharmaceutical industries limited [in] india - esomeprazol 20.00mg - tableta de liberaciÓn controlada - cada tableta de liberaciÓn controlada contiene: esomeprazol del magnesio (amorfo) 20.700mg* correspondiente a esomeprazol 20.00mg